D-Lanz to enter Indonesia

D-Lanz to enter Indonesia

GLEN ROCK, N.J. (Dow Jones): D-Lanz Development Group, Inc. (DLNZ) was given permission by Scantek Medical Inc. (SKML) to negotiate with Indonesian and Malaysian distributors to supply Scantek's BreastCare device in those countries.

Skantec holds the worldwide rights to the device, which detects abnormalities in the breast, including breast cancer.

A D-Lanz spokesman said the company will receive unspecified monetary fees from the distributors.

"There is no obligation to pay a fee to Scantek," the spokesman added.

D-Lanz plans to distribute the device in Indonesia and Malaysia in the second calendar quarter of this year.

In a press release Friday, the company said BreastCare gross margins are expected to be more than 50 percent, of sales.

D-Lanz sales figures weren't immediately available.